Empo Health completed $7 million Series A Round funding
Sector:
MedTech
Healthcare
06/24/2025
San Bruno, CA USA
Empo Health
completed $7 million Series A Round funding. Investors include
Story Ventures (lead), VTC Ventures, Ulu Ventures, SeaX Ventures, Arben Ventures, Gaingels.
"We believe that the patients most in need of health monitoring currently have the most difficult access to it. We founded Empo to change that, meeting patients where they are in their homes and giving clinicians actionable tools to significantly reduce the diabetic foot amputations that drive patient mortality and high healthcare costs. We're excited to bring our solution to patients, providers, and payors commercially," said Anuj Khandelwal, Co-Founder & CEO of Empo Health.
About
Empo Health® is a healthcare technology company focused on improving patient outcomes with novel in-home health monitoring devices. The company has developed the FDA-listed Empo® Footprint and HIPAA-compliant Empo® Remote Health Link for monitoring diabetic foot complications. Empo was incorporated in 2020 by MIT-and-Stanford-trained technical founders, is based in the San Francisco Bay Area, and is supported by VC investors, angel investors, and SBIR grants.
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
